Xiaoyu Weng
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer.
Journal: Journal of hazardous materials
Published: April 09, 2024
MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer.
Journal: International journal of oncology
Published: January 26, 2024
Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5.
Journal: EBioMedicine
Published: February 11, 2019
Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8.
Journal: Scientific reports
Published: June 10, 2016
Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: April 06, 2016
Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 10, 2015
Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
Journal: Surgery
Published: October 05, 2014
Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients.
Journal: Molecular carcinogenesis
Published: October 04, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026